Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genomic Health Inc (GHDX)

Genomic Health Inc (GHDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genomic Health Inc 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 USA

P: 650-556-9300

Description:

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.

Key Statistics

Overview:

Market Capitalization, $K 2,646,401
Shares Outstanding, K 37,289
Annual Sales, $ 394,110 K
Annual Net Income, $ 25,680 K
Last Quarter Sales, $ 114,140 K
Last Quarter Net Income, $ 15,990 K
60-Month Beta 1.00
% of Insider Shareholders 31.30%
% of Institutional Shareholders 94.00%
Float, K 25,618
% Float 68.70%

Growth:

1-Year Return 3.73%
3-Year Return 146.08%
5-Year Return 143.46%
5-Year Revenue Growth 50.65%
5-Year Earnings Growth 907.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.42 on 07/29/19
Next Earnings Date 11/05/19
Earnings Per Share ttm 1.43
EPS Growth vs. Prev Qtr 23.53%
EPS Growth vs. Prev Year 61.54%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

GHDX Ratios

Ratio
Price/Earnings ttm 49.51
Price/Earnings forward 125.37
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 19.51
Return-on-Assets (Before Tax) 15.05
Profit Margin % 6.52
Net Margin % 3.82
Debt/Equity 0.19
Price/Sales 6.70
Price/Cash Flow 48.84
Price/Book 8.27
Book Value/Share 8.56
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar